Close Menu

Somalogic

Life Technologies said this week that it plans to accelerate development of its Ion Torrent technology for proteomic applications.

SomaLogic has released SomaSuite, a software tool that provides access to multiplexed proteomic data generated by SomaLogic's Somascan proteomics assay technology.

Aushon Biosystems announced this week its plans to launch a new multiplex protein biomarker platform.

By Adam Bonislawski
Somalogic last week published in PLoS One a study offering the first data on use of its aptamer-based Somascan platform in tissue samples.

By Adam Bonislawski
Researchers at the University of Pittsburgh Cancer Institute have identified a panel of ten serum protein markers that could be used in risk assessment and the early detection of lung cancer.

By Adam Bonislawski
Biodesix said this week that it is collaborating with pharma firm Kadmon on a 620-patient Phase III clinical trial of that company's reversible tyrosine kinase inhibitor KD019.

By Adam Bonislawski
Scientists at the Forsyth Institute, Beth Israel Deaconess Medical Center, and biomarker firm Quanterix announced this week a collaboration to evaluate protein biomarkers for tuberculosis.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.